Search
Fierce Biotech: Appointment of Michel Janicot
- Pascal Kraft
- Jan 13, 2023
- 1 min read
Michel Janicot will serve in the newly created position of chief development officer.
Ymmunobio get ownership rights to NPTXR antibodies. Read more here: https://www.drugdiscoverytrends.com/ymmunobio-gets-ownership-rights-t...
Ymmunobio Signs Collaboration Agreement with YUMAB https://www.biopharmadive.com/press-release/20220614-ymmunobio-signs-collaboration-agr...
Comments